Two decentralized science altcoins are wavering after gaining support from Coinbase, the top US-based crypto exchange platform by volume.

In a new thread on the social media platform X, Coinbase announced the addition of two decentralized science (DeSci) protocols – Bio Protocol (BIO) and ResearchCoin (RSC) – to its suite of crypto products.

Following the announcements, the tokens both fell in price.

“ResearchCoin [and] Bio Protocol [are] now live on http://coinbase.com and in the Coinbase iOS and Android apps. Coinbase customers can log in to buy, sell, convert, send, receive or store these assets.”

BIO is trading for $0.0612 at time of writing, a 7.3% decrease on the day while RSC is valued at $0.493, a 34% dip in price during the last 24 hours.

Earlier this week, Coinbase also added support for RSC – a project backed by Coinbase CEO Brian Armstrong that aims to improve science communication and research – on Base, its proprietary blockchain, causing the asset to spike in price at the time.

According to its official website, Bio Protocol is a blockchain that allows users to help fund early-stage biotech, making developments faster and more accessible.

“Our mission is to reshape how biotech breakthroughs are born by enabling global communities of patients, researchers and crypto users to create user-owned research networks that fund and develop new and emerging biotechnologies from day one?.

At its core, Bio is designed to help scientists raise funds for their research, create value from that research, and capture and distribute that value via commercial successes. By breaking down traditional biotech barriers and introducing a permissionless framework, Bio can accelerate life-saving discoveries while making them more accessible to all.”

Follow us on X, Facebook and Telegram

Don’t Miss a Beat – Subscribe to get email alerts delivered directly to your inbox

Check Price Action

Surf The Daily Hodl Mix

&nbsp

Disclaimer: Opinions expressed at The Daily Hodl are not investment advice. Investors should do their due diligence before making any high-risk investments in Bitcoin, cryptocurrency or digital assets. Please be advised that your transfers and trades are at your own risk, and any losses you may incur are your responsibility. The Daily Hodl does not recommend the buying or selling of any cryptocurrencies or digital assets, nor is The Daily Hodl an investment advisor. Please note that The Daily Hodl participates in affiliate marketing.

Featured Image: Shutterstock/Salamahin/HUT Design

The top US-based crypto exchange platform Coinbase is adding support for one Ethereum (ETH)-based science research token.

In a new thread on the social media platform X, Coinbase says it’s adding ResearchCoin (RSC), the native asset of a science-based research blockchain co-founded by Coinbase chief executive Brian Armstrong, to its suite of crypto products.

“Coinbase will add support for ResearchCoin on the Base network… Trading will begin on or after 9AM PT on 31 July 2025, if liquidity conditions are met. Once sufficient supply of this asset is established trading on our RSC-USD trading pair will launch in phases.”

News of the addition preceded a spike in price for the asset, as RSC went from a low of $0.385 on July 25th to a high of $0.762 on July 31st. ResearchCoin has since stabilized and is trading for $0.741 at time of writing, a 10.7% increase during the last 24 hours.

In its official whitepaper, the developers of the project say they created it as a means of improving science research and communication.

“ResearchCoin has been created to incentivize participation in a highly collaborative and entirely open access platform, ResearchHub.

This first of its kind token serves to galvanize a community of academics and nonacademics in support of ResearchHub’s goal of creating an all-encompassing forum for the communication of academic research.

The downstream benefits of the success of such a community are significant: with adoption, silos that currently exist in the world of research are eliminated. As a result of this improved communication, the pace of research and the application of research are accelerated.”

Follow us on X, Facebook and Telegram

Don’t Miss a Beat – Subscribe to get email alerts delivered directly to your inbox

Check Price Action

Surf The Daily Hodl Mix

&nbsp

Disclaimer: Opinions expressed at The Daily Hodl are not investment advice. Investors should do their due diligence before making any high-risk investments in Bitcoin, cryptocurrency or digital assets. Please be advised that your transfers and trades are at your own risk, and any losses you may incur are your responsibility. The Daily Hodl does not recommend the buying or selling of any cryptocurrencies or digital assets, nor is The Daily Hodl an investment advisor. Please note that The Daily Hodl participates in affiliate marketing.

Featured Image: Shutterstock/robert_s

The new Bitcoin Tsunami

Finance Companies – Companies that are almost exclusively dedicated to Bitcoin accumulation are flooded with markets.

They are all more or less Strategic (MSTR) playbooks, so there is growing doubt about the best way to cherish them and compare them to each other.

“The most important indicator of the Bitcoin Treasury is the premium that trades compared to the underlying net assets, including any operating company,” wrote Greg Chipolalo, global research director at Bitcoin finance company NYDIG in a June 6 report.

On the surface, it means summing the company’s Bitcoin, cash and company’s value except for those of Bitcoin, and deducting obligations such as debt and preferred stocks. “It is this premium that allows these companies to convert Bitcoin stocks, and it works effectively as a money changer converting Bitcoin stocks,” says Cipolaro.

One of the most popular metrics, MNAV measures a company’s valuation of net asset value. In these cases, it is Bitcoin’s Ministry of Finance. MNAVs above 1.0 indicate that investors are interested in paying premiums in stock exposures compared to Bitcoin Stash. However, an MNAV below 1.0 means that fairness is less valuable than the company’s holdings.

But Mnav alone is “a terrible shortage” to analyze the pros and cons of these companies, Cipolaro said. The research report used other metrics such as NAV, MNAV measured by market capitalization, MNAV, MNAV in enterprise value, and NAV equity premium to provide more complex images.

The table shows, for example, that the premium to NAVs of Semler Scientific (SMLR) and Trump Media (DJT) (measuring the percentage of the fund’s market price and the percentage of net asset value) is the lowest of eight measured companies, which are -10% and -16%, respectively, despite the fact that they have an MNAV greater than 1.1, respectively.

Unfortunately, both SMLR and DJT will hardly change on Monday, even if Bitcoin rises to $108,500 against the $105,000 level on Friday evening. MSTR is 5% shy.